NCT06584019Completed
The Effect of Range of Motion (ROM) exercıses on Comfort Level and vıtal sıgns
The Effect of Range of Motion (ROM) Exercises Applied to Oncology Patients in the 6-12 Years Group on the Comfort Level and Vital Signs
Source: ClinicalTrials.gov · Last updated 19 Sept 2024
Brief summary (registry, in English)
This experimental study aims to examine the effects of ROM (Range of Motion) exercises on comfort level and vital signs in children diagnosed with cancer.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 19 Jul 2024
- Start date
- 1 May 2023
- Primary completion date
- 30 Dec 2023
- Lead sponsor
- Istanbul Medipol University Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT06584019
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 1 May 2023 to the primary completion date, 30 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with fractures or orthopedic conditions that may limit exercise.
- Patients with serious cardiac problems that may prevent exercise.
Who the study is looking for
- Individuals between 6 and 12 years of age.
- Patients diagnosed with oncology.
- Patients who agreed to participate in the study and whose consent was obtained from their parents.
- Patients who can communicate and are conscious.
Age in the registry: 6 years to 12 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medipol University Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.